
CMS’ coverage determination for CAR-T still delayed after a month, and nobody knows why
A legal expert said such delays from CMS are unusual. The agency said May 17 that it would delay its long-awaited national coverage determination for CAR-Ts, but since then even drugmakers haven't been given a reason or timeline.